172 related articles for article (PubMed ID: 22789848)
1. Over-expression of Stat5b confers protection against diabetes in the non-obese diabetic (NOD) mice via up-regulation of CD4(+)CD25(+) regulatory T cells.
Jin Y; Purohit S; Chen X; Yi B; She JX
Biochem Biophys Res Commun; 2012 Aug; 424(4):669-74. PubMed ID: 22789848
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
[TBL] [Abstract][Full Text] [Related]
3. Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
Yamanouchi J; Puertas MC; Verdaguer J; Lyons PA; Rainbow DB; Chamberlain G; Hunter KM; Peterson LB; Wicker LS; Santamaria P
Diabetes; 2010 Jan; 59(1):272-81. PubMed ID: 19833887
[TBL] [Abstract][Full Text] [Related]
4. Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.
Chen B; Yi B; Mao R; Liu H; Wang J; Sharma A; Peiper S; Leonard WJ; She JX
PLoS One; 2013; 8(2):e56600. PubMed ID: 23457589
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.
Vogtenhuber C; Bucher C; Highfill SL; Koch LK; Goren E; Panoskaltsis-Mortari A; Taylor PA; Farrar MA; Blazar BR
Blood; 2010 Jul; 116(3):466-74. PubMed ID: 20442366
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
8. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
9. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b.
Zerif E; Khan FU; Raki AA; Lullier V; Gris D; Dupuis G; Amrani A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899608
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
13. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes.
Ullah Khan F; Khongorzul P; Gris D; Amrani A
Int Immunopharmacol; 2024 May; 133():112166. PubMed ID: 38678673
[TBL] [Abstract][Full Text] [Related]
14. Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
James CR; Buckle I; Muscate F; Otsuka M; Nakao M; Oon JSh; Steptoe RJ; Thomas R; Hamilton-Williams EE
Immunol Cell Biol; 2016 May; 94(5):509-19. PubMed ID: 26763864
[TBL] [Abstract][Full Text] [Related]
15. Truncated pStat5B is associated with the Idd4 locus in NOD mice.
Davoodi-Semiromi A; McDuffie M; Litherland S; Clare-Salzler M
Biochem Biophys Res Commun; 2007 May; 356(3):655-61. PubMed ID: 17382905
[TBL] [Abstract][Full Text] [Related]
16. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
Waid DM; Vaitaitis GM; Pennock ND; Wagner DH
J Leukoc Biol; 2008 Aug; 84(2):431-9. PubMed ID: 18469093
[TBL] [Abstract][Full Text] [Related]
18. APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.
Manirarora JN; Kosiewicz MM; Parnell SA; Alard P
PLoS One; 2008; 3(11):e3739. PubMed ID: 19011680
[TBL] [Abstract][Full Text] [Related]
19. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.
Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y
J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877
[TBL] [Abstract][Full Text] [Related]
20. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
